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Evolution by natural selection is
something most biologists freely
talk and argue about but, perhaps
surprisingly, it is not on the lips or
curricula of most medical
students. The teaching of
medicine asks little of students to
consider the implications of
Darwin’s work. However, while
many people believe humans are
now beyond the reach of natural
selection, a growing group of
researchers believe that in some
populations and circumstances
natural selection has exerted a
powerful effect.
This link was explored in a
meeting in London last month by
the Academy of Medical Sciences
on evolution and disease. The
idea of taking a Darwinian
perspective on disease first
gained prominence with a book
on the subject published by
Randolph Nesse and George
Williams ten years ago. Since
then, many have been convinced
that an evolutionary view can
provide insights into many clinical
conditions. But uptake by
mainstream medical education
has been limited, and many
medical schools in the US still pay
scant attention, according to
research carried out by Nesse. So
one of the aims of this meeting
was to bolster the achievements
within the field.
According to David Weatherall,
former director of Weatherall
Institute of Molecular Medicine in
Oxford, and one of the conference
speakers, the subject is an
established one that produces
solid knowledge with potential
clinical use, but also one open to
considerable speculation.
He dates the field to the late
1940s, when the British biologist
J.B.S. Haldane pointed out the
high frequency of genetic blood
diseases – sickle-cell disease and
thalassaemia – in some human
populations. Haldane’s
suggestion that this may be linked
to malaria resistance was a
‘remarkable insight’ says
Weatherall. ‘It took a long time to
validate this but it turned out to
be true. Sickle cell disease itself is
very severe but people who are
carriers of the disease, and do not
have it actively, live normal lives
and are far less likely to develop
malaria,’  he says. Two years ago,
a case controlled study on
children in Papua New Guinea
showed that thalassaemia carriers
were 60 per cent less likely than
other children in the same villages
to develop severe malaria.
It is not clear how long these
adaptations have been at work,
but Weatherall suggests that they
date back about 5,000 years. And
studies by Weatherall and his
colleagues and other teams have
shown that mutations protecting
against the disease differ
between different populations. ‘It
appears the mutations are local
and are subject to local selection,’
he says. However, studies by his
group in the the Pacific island
group of Vanuatu reveal that
similar patterns of mutations are
found on some neighbouring
islands, including some where
malaria is not found. But this
puzzling pattern fits with current
views on how and when humans
colonised these islands.
Researchers have also found
that the frequency of mutations in
the populations exposed to
malaria  vary and are often
highest in areas where the
disease is most prevalent, again
showing the importance of local
factors.
Two species of malaria are
dominant in causing human
disease: Plasmodium falciparum
and P. vivax. The two species co-
exist in many parts of the world
but P. vivax is notably absent
from West Africa. This
observation led to the classic
discovery that the erythrocytes of
the Duffy blood group negative
individuals, who predominate in
this region, are resistant to
invasion by P. vivax but not by
other species of malaria parasite. 
Thalassaemia and sickle-cell
disease are only the best-known
adaptations to malaria. But the
disease is such a danger across
the tropical world that a wide
range of countermeasures have
emerged to fight it. Weatherall
says there are millions of children
with an enzyme defect that makes
their red blood cells more likely to
break up, which is doubtless
malaria related.
Malaria is not the only such
case, however. There are people
whose genes make them more
resistant to HIV/Aids. Over time
this polymorphism might be
expected to spread, as those
against malaria have in the
tropics, although, Weatherall
says, nobody knows how this
particular polymorphism came to
be there in the first place. HIV has
not been in contact with the
human population long enough
for resistance to it to convey a
reproductive advantage, which
would let it spread by natural
selection. Instead, it may in the
past have conveyed resistance to
virus infections that are no longer
problematic.
One of the issues addressed at
the meeting was how fast
evolution works. Weatherall’s
estimates suggest that the
process can be very fast when the
pressure is strong – it may take
just decades for the proportion of
people with innate resistance to
increase in a case such as Aids,
for example. This kind of rapid
effect is also likely to be the
cause of a large amount of human
diversity, such as the existence of
different blood groups. These
involve different blood proteins
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and different patterns of
susceptibility to disease.
More examples of genetic
variation in the face of disease
are likely to emerge because the
technology for analyzing genes
and their variability is advancing
fast. Knowing about the different
forms of relative resistance to a
disease might also lead to new
ways of managing it. And if a new
vaccine is being tested for its
ability to attenuate malaria
attacks, for example, it would
help to know what percentage of
the population is already immune
before testing it.
Some of the human diseases
that evolution may also provide
an insight to include diabetes,
breast cancer, obesity, hip
fracture and depression. All of
these are increasing in incidence
in western  societies. The gap
between our ancient hunter-
gather environments and present-
day environments is thought by
many to hold a clue to these
problems. Pinning down answers
is more difficult but many hope an
evolutionary approach will help.
Evolutionary medicine is also
contributing thought on the
production and mutation of
cancer cells. While childhood
cancers exist, most cancers
affect older people, and there has
been speculation that they tend
to appear when people have
become old enough to have
reproduced. At this stage the
repair mechanisms that protect
younger people run out. Mel
Greaves, head of the Leukaemia
Research Fund Centre at the
Institute of Cancer Research in
London, who has also written a
recent book on the evolutionary
legacy of cancer,  highlighted the
particular role of stem cells where
there is a conflict between their
role as a source of tissue
replenishment throughout life but
where such longevity renders
them a major target for cancerous
transformation.
Many in the field regard the
evolutionary perspective as a
counterbalance to the belief of
some scientists who think that
natural selection is no longer
operating on human populations.
‘In Africa, where malaria kills a
million people every year and
Aids even more, very rapid
selection is still going on,’ says
Weatherall. And even in the
developed world the evolutionary
approach has something to offer.
The connection between cancer
and tobacco is clear. But work on
diet and cancer has been less
successful, while cancer risks
from ionizing radiation and other
hazards such as the oxidants that
result from our own metabolism
also need more work. ‘In time our
knowledge of the genetic make-
up of the population is likely to be
reflected in public health and
treatment protocols,’ says
Weatherall. Medical students and
their teachers may then need to
sit up and listen.
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Deadly pressures: A mother comforts  her child undergoing treatment for severe malaria in a children’s ward at a hospital in
Tanzania. It is estimated 1 million people die of the disease in Africa every year putting strong selection pressure on the affected
populations. (Photograph: Andy Trump TDR/WHO, Science Photo Library.) 
